CD70-targeted immunoPET Imaging of Malignant Cancers

Abroad (travel likely)RecruitingPHASE2

Conditions

Renal Cancer · Renal Clear Cell Carcinoma · Lymphoma · Lymphoma, Large B-Cell, Diffuse · Follicular Lymphoma · Mantle Cell Lymphoma · Nasopharyngeal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Contact: Study coordinator (Weijun Wei) · wwei@shsmu.edu.cn · 15000083153
Contact: Study coordinator (Shuxian An) · anshuxian@shsmu.edu.cn · 17717453484

Study leads

Jianjun Liu, Ph.D. & M.D.
Study Chair
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Weijun Wei, Ph.D. & M.D.
Principal Investigator
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Brain Cancer · Breast Cancer · Bladder Cancer

Abroad (travel likely)Recruiting

Duarte, United States · Miami, United States

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Neoplasms · Kidney Neoplasms · Urologic Neoplasms

Abroad (travel likely)Recruiting

Nanjing, China

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Biliary Tract Cancer · Breast Cancer · Cervical Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Denver, United States · Miami, United States

64Cu-GRIP B in Patients With Advanced Malignancies

Prostate Cancer · Renal Cancer · Urethral Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Francisco, United States